Results 111 to 120 of about 29,347 (276)

Epidemiological approaches to evaluate clinical unmasking of HPV‐associated cervical lesions in the HPV vaccination era

open access: yesInternational Journal of Cancer, Volume 158, Issue 4, Page 847-857, 15 February 2026.
Abstract HPV vaccination reduces the risk of developing HPV‐attributable cancers, including cervical cancer. However, an attenuation of HPV vaccine impact after the implementation of HPV vaccination may occur through clinical unmasking. Clinical unmasking is a distinct and complex phenomenon that arises in the absence of clinical interventions ...
Joseph E. Tota   +8 more
wiley   +1 more source

Cervical, vaginal and vulvar intraepithelial neoplasms [PDF]

open access: yes, 2011
nem
Mitrović-Jovanović Ana   +5 more
core   +1 more source

Spatial evidence for carcinoma in situ (CIS) as an entity in human papillomavirus (HPV)‐associated tonsillar squamous cell carcinoma (TSCC)

open access: yesInternational Journal of Cancer, Volume 158, Issue 4, Page 1080-1092, 15 February 2026.
What's new? Human papillomavirus (HPV)‐associated tonsillar squamous cell carcinoma (TSCC) is suspected of originating from tonsillar crypts, where HPV can persist in latent form. Detection is further complicated by the possible absence of premalignant stages, namely carcinoma in situ (CIS). Here, the authors investigated tumor origin in HPV‐associated
Tobias Näsman   +3 more
wiley   +1 more source

A case of HPV-53-related cervical cancer in an elderly patient [PDF]

open access: yes, 2014
Zappacosta et al1 recently published a case report concerning a human papillomavirus (HPV)-positive invasive cervical cancer in a 79-year-old women who had a history of normal Pap smears.
Lieveld, Marusya   +3 more
core   +3 more sources

Increased Risk of Second Squamous Cell Carcinomas Following Cervical Cancer: A Nationwide Danish Case–Control Study

open access: yesCancer Medicine, Volume 15, Issue 2, February 2026.
ABSTRACT Introduction This nationwide case–control study investigated the risk of second primary cancers among cervical cancer (CC) survivors compared to cancer‐free women. Methods Women aged ≥ 18 diagnosed with CC from 1987 to 2012 were identified via the Danish Cancer Registry (DCR) and matched 1:5 by age and residence to cancer‐free controls.
Sara Bønløkke   +3 more
wiley   +1 more source

Vulvar yolk sac tumor mixed with embryonal carcinoma in a peri-pubertal girl: A case report

open access: yesTaiwanese Journal of Obstetrics & Gynecology, 2011
Objective: Vulvar cancer is rare in Eastern females, especially in pre- and peripubertal girls. The prognosis of vulvar cancer is poor and treatment is variable.
Cherry Yin-Yi Chang   +6 more
doaj   +1 more source

Indocyanine green utility in sentinel node detection for cervical cancer patients [PDF]

open access: yes, 2019
With wide implementation of screening tests for the Human Papilloma Virus, the number of diagnosed cases of premalignant or early stages of cervical cancer has increased considerably.
Bacalbașa, Nicolae   +4 more
core   +2 more sources

Harnessing viral footprints in circulating free DNA (cfDNA) for early cancer detection: A focus on liquid‐biopsy‐based screening

open access: yesInternational Journal of Cancer, Volume 158, Issue 3, Page 511-526, 1 February 2026.
Abstract Viral infections play a significant role in cancer development, making detecting viral signatures a promising approach for early cancer diagnosis. Circulating free DNA (cfDNA), released into the bloodstream by tumors and other cells, has emerged as a powerful biomarker for non‐invasive cancer screening.
Richard Donkor Amponsah   +4 more
wiley   +1 more source

Genomics of cervical, vulvar and vaginal cancers and the potential of precision medicine

open access: yesTherapeutic Advances in Medical Oncology
Most cases of cervical cancer are still caused by persistent infection with high-risk human papillomavirus (HPV) variants, which also drives the development of ~30% of vulvar and ~76% of vaginal malignancies.
Holly E. Barker   +3 more
doaj   +1 more source

Radical resection and sentinel lymph node evaluation of mammary-like adenocarcinoma of the vulva (MLAV) with somatic BRCA1 mutation

open access: yesGynecologic Oncology Reports
Background: Mammary-like gland adenocarcinoma of the vulva is a rare and aggressive form of vulvar cancer with histopathologic resemblance to breast cancer.
Lilla Markel   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy